BTAIVSPCSA• 12 Months (Normalized)
BTAI vs PCSA (BioXcel Therapeutics Inc. vs Processa Pharmaceuticals Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-98.5%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
PCSA Performance $2.08
-56.67%
Processa Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin PCSA LEADS
-41.83%
PCSA outperforming by 41.83%
BTAIPCSA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI PCSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BTAI Price | BTAI Gain (%) | PCSA Price | PCSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -98.50% | $2.08 | -56.67% | -41.83% |
| Sep 10, 2026 | $0.05 | -98.53% | $1.85 | -61.46% | -37.07% |
| Sep 09, 2026 | $0.05 | -98.61% | $1.99 | -58.54% | -40.07% |
| Sep 08, 2026 | $0.04 | -98.73% | $2.16 | -55.00% | -43.73% |
| Sep 04, 2026 | $0.07 | -97.82% | $2.06 | -57.08% | -40.74% |
| Sep 03, 2026 | $0.12 | -96.52% | $2.05 | -57.29% | -39.23% |
| Sep 02, 2026 | $0.11 | -96.84% | $2.10 | -56.25% | -40.59% |
| Sep 01, 2026 | $0.14 | -95.96% | $2.05 | -57.29% | -38.67% |
| Aug 31, 2026 | $0.16 | -95.19% | $2.05 | -57.29% | -37.90% |
| Aug 28, 2026 | $0.18 | -94.66% | $2.06 | -57.08% | -37.58% |
| Aug 27, 2026 | $0.72 | -78.79% | $2.11 | -56.04% | -22.75% |
| Aug 26, 2026 | $0.78 | -76.99% | $2.13 | -55.63% | -21.36% |
| Aug 25, 2026 | $0.74 | -78.11% | $2.18 | -54.58% | -23.53% |
| Aug 24, 2026 | $0.76 | -77.55% | $2.17 | -54.79% | -22.76% |
| Aug 21, 2026 | $0.80 | -76.28% | $2.08 | -56.67% | -19.61% |
Page 1 of 17